Dasatinib is a kinase inhibitor used to treat certain types of leukemia in both adults and children 1 year of age and older, including cases where previous treatment were not effective or tolerated.
The Rx Report finds that 76% of consumers have had at least one active prescription for themselves or those they care for, and 79% have visited a pharmacy in the past year.